Heart ablation showdown: which technique stops fainting best?
NCT ID NCT07162740
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study tests two heart ablation methods—right atrial only vs. bi-atrial—to see which better prevents fainting caused by reflex syncope. Fifty adults aged 18–60 with severe, recurrent fainting will be monitored with an implantable loop recorder. The goal is to find the most effective and safe technique to reduce asystolic episodes.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cardioneuroablation (a procedure that uses heat to disable nerve clusters in the heart)
What this could lead to
If successful, this study could identify the best ablation technique to reduce or prevent fainting spells in people with reflex syncope.
What could go wrong
This is a small, early-stage study (50 people) comparing two existing procedures, so results may not apply broadly. Ablation carries risks like bleeding, infection, or heart rhythm issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for REFLEX SYNCOPE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
IRCCS Istituto Auxologico Italiano
Milan, 20149, Italy